- Home
- GH vs TCBI Comparison
GH vs TCBI Comparison
Compare GH & TCBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- TCBI
- Stock Information
- Founded
- GH 2011
- TCBI 1996
- Country
- GH United States
- TCBI United States
- Employees
- GH N/A
- TCBI N/A
- Industry
- GH Medical Specialities
- TCBI Major Banks
- Sector
- GH Health Care
- TCBI Finance
- Exchange
- GH Nasdaq
- TCBI Nasdaq
- Market Cap
- GH 4.9B
- TCBI 3.9B
- IPO Year
- GH 2018
- TCBI N/A
- Fundamental
- Price
- GH $54.62
- TCBI $85.95
- Analyst Decision
- GH Strong Buy
- TCBI Hold
- Analyst Count
- GH 17
- TCBI 13
- Target Price
- GH $58.24
- TCBI $82.77
- AVG Volume (30 Days)
- GH 2.4M
- TCBI 433.8K
- Earning Date
- GH 11-05-2025
- TCBI 10-16-2025
- Dividend Yield
- GH N/A
- TCBI N/A
- EPS Growth
- GH N/A
- TCBI N/A
- EPS
- GH N/A
- TCBI 2.50
- Revenue
- GH $828,849,000.00
- TCBI $936,954,000.00
- Revenue This Year
- GH $28.07
- TCBI $47.34
- Revenue Next Year
- GH $21.61
- TCBI $9.49
- P/E Ratio
- GH N/A
- TCBI $34.73
- Revenue Growth
- GH 28.74
- TCBI N/A
- 52 Week Low
- GH $20.14
- TCBI $59.37
- 52 Week High
- GH $68.00
- TCBI $94.61
- Technical
- Relative Strength Index (RSI)
- GH 41.10
- TCBI 50.23
- Support Level
- GH $53.67
- TCBI $86.20
- Resistance Level
- GH $61.95
- TCBI $87.81
- Average True Range (ATR)
- GH 2.29
- TCBI 1.57
- MACD
- GH -1.51
- TCBI -0.10
- Stochastic Oscillator
- GH 7.33
- TCBI 23.28
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About TCBI Texas Capital Bancshares Inc.
Texas Capital Bancshares Inc is a registered bank holding company and a full-service financial services firm that delivers customised solutions to businesses, entrepreneurs and individual customers. It is a secured lender with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. Texas Capital has established commercial banking, consumer banking, investment banking and wealth management capabilities.